头颈部癌质子治疗基于模型选择的国家协议。
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.
作者信息
Langendijk Johannes A, Hoebers Frank J P, de Jong Martin A, Doornaert Patricia, Terhaard Chris H J, Steenbakkers Roel J H M, Hamming-Vrieze Olga, van de Kamer Jeroen B, Verbakel Wilko F A R, Keskin-Cambay Fatma, Reitsma Johannes B, van der Schaaf Arjen, Boersma Liesbeth J, Schuit Ewoud
机构信息
Department of Radiation Oncology, University of Groningen, University Medical Centre Groningen, Groningen, the Netherlands.
Department of Radiation Oncology (MAASTRO clinic), GROW School for Oncology and Developmental Biology, Maastricht University Medical Centre, the Netherlands.
出版信息
Int J Part Ther. 2021 Jun 25;8(1):354-365. doi: 10.14338/IJPT-20-00089.1. eCollection 2021 Summer.
Abstract
In the Netherlands, the model-based approach is used to identify patients with head and neck cancer who may benefit most from proton therapy in terms of prevention of late radiation-induced side effects in comparison with photon therapy. To this purpose, a National Indication Protocol Proton therapy for Head and Neck Cancer patients (NIPP-HNC) was developed, which has been approved by the health care authorities. When patients qualify according to the guidelines of the NIPP-HNC, proton therapy is fully reimbursed. This article describes the procedures that were followed to develop this NIPP-HNC and provides all necessary information to introduce model-based selection for patients with head and neck cancer into routine clinical practice.
摘要
在荷兰，基于模型的方法用于识别头颈癌患者，这些患者与光子治疗相比，在预防晚期辐射诱发副作用方面可能从质子治疗中获益最多。为此，制定了一项针对头颈癌患者的国家质子治疗适应症协议（NIPP-HNC），该协议已获得医疗保健当局的批准。当患者符合NIPP-HNC的指导方针时，质子治疗可全额报销。本文描述了制定该NIPP-HNC所遵循的程序，并提供了将基于模型的头颈癌患者选择方法引入常规临床实践所需的所有信息。
相似文献
1
National Protocol for Model-Based Selection for Proton Therapy in Head and Neck Cancer.
Int J Part Ther. 2021 Jun 25;8(1):354-365. doi: 10.14338/IJPT-20-00089.1. eCollection 2021 Summer.
2
Model-Based Selection for Proton Therapy in Breast Cancer: Development of the National Indication Protocol for Proton Therapy and First Clinical Experiences.
Clin Oncol (R Coll Radiol). 2022 Apr;34(4):247-257. doi: 10.1016/j.clon.2021.12.007. Epub 2022 Jan 5.
3
First experience with model-based selection of head and neck cancer patients for proton therapy.
Radiother Oncol. 2020 Oct;151:206-213. doi: 10.1016/j.radonc.2020.07.056. Epub 2020 Aug 6.
4
A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2019 Jul 1;104(3):540-552. doi: 10.1016/j.ijrobp.2018.11.039. Epub 2018 Nov 26.
5
Proton Beam Reirradiation for Recurrent Head and Neck Cancer: Multi-institutional Report on Feasibility and Early Outcomes.
Int J Radiat Oncol Biol Phys. 2016 May 1;95(1):386-395. doi: 10.1016/j.ijrobp.2016.02.036. Epub 2016 Feb 17.
6
Cost and Healthcare Utilization Among Non-Elderly Head and Neck Cancer Patients in the Military Health System, a Single-Payer Universal Health Care Model.
Mil Med. 2019 May 1;184(5-6):e400-e407. doi: 10.1093/milmed/usy192.
7
Financial Toxicity in Head and Neck Cancer Patients Treated With Proton Therapy.
Int J Part Ther. 2021 Jun 25;8(1):366-373. doi: 10.14338/IJPT-20-00054.1. eCollection 2021 Summer.
8
Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
Oral Oncol. 2019 Jan;88:66-74. doi: 10.1016/j.oraloncology.2018.11.015. Epub 2018 Nov 21.
9
Documentation and incidence of late effects and screening recommendations for adolescent and young adult head and neck cancer survivors treated with radiotherapy.
Support Care Cancer. 2019 Jul;27(7):2609-2616. doi: 10.1007/s00520-018-4559-5. Epub 2018 Nov 22.
10
Head and Neck Cancer Survivorship Care Guideline: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of the American Cancer Society Guideline.
J Clin Oncol. 2017 May 10;35(14):1606-1621. doi: 10.1200/JCO.2016.71.8478. Epub 2017 Feb 27.
引用本文的文献
1
Hybrid proton planning combining spread-out Bragg peak beams with transmission beams to shorten field delivery times while maintaining plan quality.
Phys Imaging Radiat Oncol. 2025 Jul 11;35:100809. doi: 10.1016/j.phro.2025.100809. eCollection 2025 Jul.
2
Early generation dynamic and static proton arc treatment planning algorithms assessment in oropharyngeal cancer patients.
Med Phys. 2025 Jul;52(7):e17916. doi: 10.1002/mp.17916.
3
Transfer learning for DL-based Synthetic CT after reconstruction algorithm upgrade in a proton therapy clinic.
Med Phys. 2025 Jul;52(7):e17937. doi: 10.1002/mp.17937.
4
Evidence-based guideline diagnosis, treatment, prevention and aftercare of oropharyngeal and hypopharyngeal carcinoma.
Ger Med Sci. 2025 Jun 24;23:Doc03. doi: 10.3205/000339. eCollection 2025.
5
The proton therapy research beamline at the Christie NHS foundation trust.
Biomed Phys Eng Express. 2025 Jul 25;11(4):045036. doi: 10.1088/2057-1976/addbe8.
6
Proton Therapy Patient Selection Methods and the Impact of COVID-19: A Cross-Sectional International Survey.
J Med Radiat Sci. 2025 Sep;72(3):333-340. doi: 10.1002/jmrs.885. Epub 2025 May 11.
7
Envisioning an Italian Head and Neck Proton Therapy Model-Based Selection: Challenge and Opportunity.
Int J Part Ther. 2025 Mar 20;16:100745. doi: 10.1016/j.ijpt.2025.100745. eCollection 2025 Jun.
8
Evaluation of a comprehensive set of normal tissue complication probability models for patients with head and neck cancer in an international cohort.
Oral Oncol. 2025 Apr;163:107224. doi: 10.1016/j.oraloncology.2025.107224. Epub 2025 Mar 1.
9
Enhancing accuracy in proton therapy: The impact of geometric uncertainty models in head and neck cancer treatment.
Med Phys. 2025 Jun;52(6):4585-4589. doi: 10.1002/mp.17698. Epub 2025 Feb 21.
10
Treatment-related toxicity, utility and patient-reported outcomes of head and neck cancer patients treated with proton therapy: A longitudinal study.
Clin Transl Radiat Oncol. 2025 Jan 9;51:100913. doi: 10.1016/j.ctro.2025.100913. eCollection 2025 Mar.
本文引用的文献
1
First experience with model-based selection of head and neck cancer patients for proton therapy.
Radiother Oncol. 2020 Oct;151:206-213. doi: 10.1016/j.radonc.2020.07.056. Epub 2020 Aug 6.
2
Key challenges in normal tissue complication probability model development and validation: towards a comprehensive strategy.
Radiother Oncol. 2020 Jul;148:151-156. doi: 10.1016/j.radonc.2020.04.012. Epub 2020 Apr 23.
3
Clinical Trial Strategies to Compare Protons With Photons.
Semin Radiat Oncol. 2018 Apr;28(2):79-87. doi: 10.1016/j.semradonc.2017.11.008.
4
Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk.
Clin Oncol (R Coll Radiol). 2017 Apr;29(4):263-273. doi: 10.1016/j.clon.2016.12.001. Epub 2017 Jan 3.
5
A closed testing procedure to select an appropriate method for updating prediction models.
Stat Med. 2017 Dec 10;36(28):4529-4539. doi: 10.1002/sim.7179. Epub 2016 Nov 28.
6
Predictors of Dysgeusia in Patients With Oropharyngeal Cancer Treated With Chemotherapy and Intensity Modulated Radiation Therapy.
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):354-361. doi: 10.1016/j.ijrobp.2016.05.011. Epub 2016 May 17.
7
Intensity-modulated proton beam therapy (IMPT) versus intensity-modulated photon therapy (IMRT) for patients with oropharynx cancer - A case matched analysis.
Radiother Oncol. 2016 Jul;120(1):48-55. doi: 10.1016/j.radonc.2016.05.022. Epub 2016 Jun 21.
8
Normal tissue complication probability (NTCP) modelling using spatial dose metrics and machine learning methods for severe acute oral mucositis resulting from head and neck radiotherapy.
Radiother Oncol. 2016 Jul;120(1):21-7. doi: 10.1016/j.radonc.2016.05.015. Epub 2016 May 27.
9
Swallowing sparing intensity modulated radiotherapy (SW-IMRT) in head and neck cancer: Clinical validation according to the model-based approach.
Radiother Oncol. 2016 Feb;118(2):298-303. doi: 10.1016/j.radonc.2015.11.009. Epub 2015 Dec 14.
10
Patient- and therapy-related factors associated with the incidence of xerostomia in nasopharyngeal carcinoma patients receiving parotid-sparing helical tomotherapy.
Sci Rep. 2015 Aug 20;5:13165. doi: 10.1038/srep13165.
Zotero 插件